[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356755-105":59,"doc-detail-356755-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","liquid-biopsy-reveals-the-immune-status-and-protein-profiles-linked-to-ctc-burden-and-clinical-outcomes-in-metastatic-breast-cancer","Liquid biopsy reveals the immune status and protein profiles linked to CTC burden and clinical outcomes in metastatic breast cancer","","Metastatic breast cancer remains a major therapeutic challenge because systemic immune dysfunction and vascular remodeling support dissemination and treatment resistance. This prospective study applied multilayered liquid biopsy to map the systemic immunovascular landscape and to find circulating biomarkers tied to progression and risk stratification. Peripheral blood from 60 stage IV patients was analyzed for circulating tumor cells, immune phenotypes by flow cytometry, and plasma proteomics, with survival associations tested using Kaplan–Meier and Cox modeling.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/liquid-biopsy-reveals-the-immune-status-and-protein-profiles-linked-to-ctc-burden-and-clinical-outcomes-in-metastatic-breast-cancer/356755/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/liquid-biopsy-reveals-the-immune-status-and-protein-profiles-linked-to-ctc-burden-and-clinical-outcomes-in-metastatic-breast-cancer/356755.png","ImageObject",300,407,{"name":92,"@type":93},"Bintang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What patient population and sampling timing were used in the study?","Question",{"text":113,"@type":114},"Peripheral blood samples were collected from 60 patients at diagnosis of stage IV metastatic breast cancer before treatment initiation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were circulating tumor cells, immune cells, and proteins measured?",{"text":118,"@type":114},"Circulating tumor cells were enumerated with the CellSearch® system, immune profiling was performed by flow cytometry, and plasma proteomic analysis used the Olink® 96 ImmunoOncology panel.",{"name":120,"@type":111,"acceptedAnswer":121},"Which biomarkers were identified as independent predictors of progression-free survival?",{"text":122,"@type":114},"Multivariate Cox analysis identified IL-8 (HR = 1.49, p = 0.004) and NOS3 (HR = 4.72, p = 0.003) as independent PFS predictors.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356755,1790254196,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Kurma et al. Journal of Experimental & Clinical Cancer Research (2026) 45:111 [https://doi.org/10.1186/s13046-026-03709-3](https://doi.org/10.1186/s13046-026-03709-3)  \nJournal of Experimental & Clinical Cancer Research  \nRESEARCH Open Access  \nLiquid biopsy reveals the immune status and protein profiles linked to CTC burden and clinical outcomes in metastatic breast cancer  \nKeerthi Kurma 1,2,3, Thomas Bardol1,2,3, Caroline Mollevi4, Zahra Eslami-S 1,2,3, Françoise Garima1,2,3, Marie Alexandre5, Angélique Bobrie5,6, Gerald Lossaint7, Blandine Massemin8, Véronique D’Hondt5,6, Séverine Guiu5,6,  \nLaure Cayrefourcq1,2,3, William Jacot5,6 and Catherine Alix-Panabières1,2,3*  \nAbstract  \nBackground Metastatic breast cancer (mBC) remains a major therapeutic challenge. Increasing evidence suggests that metastatic dissemination and resistance to treatment are sustained by systemic immune dysfunction and vascular remodeling. Yet, the underpinning mechanisms remain incompletely understood. Therefore, we applied a multilayered liquid biopsy strategy to characterize the systemic immunovascular landscape of mBC and identify clinically actionable circulating biomarkers of disease progression and risk stratification.  \nMethods In this prospective study, peripheral blood samples were collected from 60 patients at diagnosis of stage IV mBC before treatment initiation. Circulating tumor cells (CTCs) were enumerated with the CellSearch® system. Immune profiling was performed by flow cytometry, and plasma proteomic analysis using the Olink® 96 ImmunoOncology panel. Progression-free survival (PFS) was analyzed using Kaplan–Meier and Cox proportional hazards models, including multivariate analysis to identify independent prognostic factors.  \nResults Tumors were mainly HR⁺/HER2 ⁻ (83 . 3%), and the median follow-up and progression-free survival (PFS) were 31.5 months and 19.9 months, respectively. CTCs were detected in 58. 3% of patients (range: 1–962 CTCs/7 .5 mL blood) . Comprehensive immune profiling revealed that total leukocytes and CD3⁺ T cells were strongly reduced and regulatory T cells (Tregs; CD4⁺CD25highCD127low/–), which expressed various inhibitory receptors (PD-1, CTLA- 4, TIGIT, LAG-3), were increased in patient’s vs. age-matched healthy donors. The co-expression of PD-1, CTLA-4, LAG-3 and TIGIT in effectorT cells (CD4⁺, CD8⁺) indicated exhaustion. Circulating monocytes/macrophages exhibited a shift toward the immunosuppressive CD163⁺CD206⁺ phenotype. Plasma proteomic profiling identified an inflammatory and angiogenic signature (elevated IL-6, IL-8, HGF, ANGPT2, NOS3, CSF1 and galectin-9, and reduced FASLG and TWEAK expression) . Notably, Treg proportion and IL-8, HGF, galectin-9 and TNFRSF12A levels were higher in CTC-positive than CTC-negative patients. Liver metastases, triple-negative receptor status, and high CTC count  \n*Correspondence:  \nCatherine Alix-Panabières [c-panabieres@chu-montpellier.fr](c-panabieres@chu-montpellier.fr)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The)[. The](http://cr","cbCaig4yQOpfV8Tl","https://ap.wps.com/l/cbCaig4yQOpfV8Tl","pdf",2936329,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What patient population and sampling timing were used in the study?\",\"answer\":\"Peripheral blood samples were collected from 60 patients at diagnosis of stage IV metastatic breast cancer before treatment initiation.\"},{\"question\":\"How were circulating tumor cells, immune cells, and proteins measured?\",\"answer\":\"Circulating tumor cells were enumerated with the CellSearch® system, immune profiling was performed by flow cytometry, and plasma proteomic analysis used the Olink® 96 ImmunoOncology panel.\"},{\"question\":\"Which biomarkers were identified as independent predictors of progression-free survival?\",\"answer\":\"Multivariate Cox analysis identified IL-8 (HR = 1.49, p = 0.004) and NOS3 (HR = 4.72, p = 0.003) as independent PFS predictors.\"}]","Liquid biopsy reveals the immune status and protein profiles linked to CTC burden and clinical outcomes in metastatic breast cancer | PDF",1790127140,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b009680b864344c9baff0607c98bbd9a.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c83569844ec12c1655dc76cd894b25ff.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/048aa4ab5f149d7336c2ab05f70e6d49.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36e6dd83a61989df34ea211a19c24b52.webp",980,1306]